Below you will find a list of the trials and studies being run by members of Pancreatic Cancer Research Programme at the Centre.
Tissue/blood collection
PORTICO-Trans: A feasibility study looking at the immune system in tumours, comparing samples collected during surgery to those taken afterwards
Learn MoreLocally advanced
GRECO-2: A Randomised, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer
Learn MoreOperable PDAC
Portico-SABR: Investigate the effects and safety of SABR treatment given to patients with operable pancreatic cancer prior to surgery to remove the tumour
Learn MoreMetastatic - 1st or 2nd line
daNIS-2: A randomised, double-blind, phase III study comparing NIS793 in combination with gemcitabine and nab-paclitaxel versus placebo combined with gemcitabine and nab-paclitaxel for first line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC)
Learn MoreMetastatic - 2nd line and beyond
Porcupine 2: A Modular, Phase II, Open-Label, Multicentre Study to Assess the Preliminary Efficacy and Safety of RXC004, in Patients with Advanced Solid Tumours that have Progressed following Therapy with Current Standard of Care who have the RNF43 rearrangement.
Learn More